akhatri

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance regarding the transition to the new formulation and risk of medication error with Rybelsus® tablets. There is a risk of patient harm arising through medication error during a transition period where the original and new formulation of Rybelsus® tablets, which have different stated mg [...]

The post MHRA Drug Safety Update: Rybelsus® (semaglutide tablets): transition to new formulation and risk of medication error appeared first on Community Pharmacy England.

Update 08/01/2026: Alzest transdermal patches (Dr Reddy’s Laboratories (UK) Ltd) in all strengths have been discontinued. Please note: Care is needed if switching between daily and twice weekly (Zeyzelf) rivastigmine patches to avoid the risk of dosing error. The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: [...]

The post Medicine Supply Notification: Rivastigmine 4.6mg/24hours and 9.5mg/24hours transdermal patches appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 December 2025. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose ampoules Teva UK Ltd 20 unit dose    [...]

The post 6 products re-classified as special containers from December 2025 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has announced that the NHS prescription charge will remain at £9.90 per prescription item for 2026/27. A Government press release today confirms that the NHS prescription charge will be frozen, as well as the costs for prescription prepayment certificates (PPCs). The list of 2026/27 prescription-related charges are outlined below. [...]

The post NHS prescription charges frozen for the second year running appeared first on Community Pharmacy England.

National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy National Patient Safety Alert Reference Number: NatPSA/2025/006/NHSPS Date issued: 20 November 2025 Explanation of identified safety issue There are reports of healthcare staff recording a patient’s penicillin allergy as a penicillamine allergy in electronic prescribing systems. This look-alike sound-alike [...]

The post National Patient Safety Alert: Harm from incorrect recording of a penicillin allergy as a penicillamine allergy appeared first on Community Pharmacy England.